Polymerase chain reaction analyses should be used as a basis for clinical decision making in patients with chronic myelogenous leukemia.
Moravcová
J
J
Nádvorníková
S
S
Lukásová
M
M
Klamová
H
H
D014408:Biomarkers, Tumor / Q000032:analysis; D016044:Fusion Proteins, bcr-abl / Q000032:analysis / Q000235:genetics; D006801:Humans; D015464:Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Q000175:diagnosis*; D018365:Neoplasm, Residual / Q000175:diagnosis; D016133:Polymerase Chain Reaction / Q000379:methods*
D014408:Biomarkers, Tumor; D016044:Fusion Proteins, bcr-abl